A. Ribeiro-Oliveira Jr., A. I. Nogueira, R. M. Pereira, W. W. Boas, R. A. Dos Santos and A. C. Simoes e Silva, “The Renin-Angiotensin System and Diabetes: An Update,” Journal of Vascular Health and Risk Management, Vol. 4, No. 4, 2008, pp. 787-803.
 T. P. Wong, K. Y. Ho, E. K. Ng, E. S. Debnam and P. S. Leung, “Upregulation of ACE2-ANG-(1-7)-Mas Axis in Jejunal Enterocytes of Type 1 Diabetic Rats: Implications for Glucose Transport,” American Journal of Physiology, Endocrinology and Metabolism, Vol. 303, No. 5, 2012, pp. E669-E681.
 G. Li, N. Xi and D. H. Wang, “Investigation of Angiotensin II Type 1 Receptor by Atomic Force Microscopy with Functionalized Tip,” Nanomedicine, Vol. 1, No. 4, 2005, pp. 306-312.
 S. Arumugam, R. A. Thandavarayan, S. S. Palaniyandi, et al., “Candesartan Cilexetil Protects from Cardiac Myosin Induced Cardiotoxicity via Reduction of Endoplasmic Reticulum Stress and Apoptosis in Rats: Involvement of ACE2-Ang(1-7)-Mas Axis,” Toxicology, Vol. 291, No. 1-3, 2012, pp. 139-145. http://dx.doi.org/10.1016/j.tox.2011.11.008
 Y. R. Qian, Y. Guo, H. Y. Wan, L. Fan, Y. Feng, L. Ni, Y. Xiang and Q. Y. Li, “Angiotensin-Converting Enzyme 2 Attenuates the Metastasis of Non-Small Cell Lung Cancer through Inhibition of Epithelial-Mesenchymal Transition,” Oncology Reports, Vol. 29, No. 6, 2003, pp. 2408-2414.
 J. R. Puddefoot, U. D. K. Udeozo, S. Barker and G. P. Vinson, “The Role of Angiotensin II in the Regulation of Breast Cancer Cell Adhesion and Invasion,” Endocrine-Related Cancer, Vol. 13, No. 3, 2006, pp. 895-903. http://dx.doi.org/10.1677/erc.1.01136
 Y. Feng, H. Wan, J. Liu, et al., “The Angiotensin-Converting Enzyme 2 in Tumor Growth and Tumor-Associated Angiogenesis in Non-Small Cell Lung Cancer,” Oncology Reports, Vol. 23, No. 4, 2010, pp. 941-948.
 S. A. A. C. Noronha, W. Bernardo, A. J. Barros, C. R. Nakaie, S. I. Shimuta, I. D. C. G. Silva and S. M. R. Noronha, “Effects on Cell Viability and on Apoptosis in Tumoral (MCF-7) and in Normal (MCF10A) Epithelial Breast Cells after Human Chorionic Gonadotropin and Derivated-Angiotensin Peptides Treatments,” Journal of Cancer Therapy, Vol. 4, No. 7, 2013, pp. 65-69.
 I. Binda Neto, S. M. R. Noronha, S. A. A. C. Noronha, M. D. C. M. Wolgien, A. J. Barros, C. R. Nakaie, S. I. Shimuta, G. Facina and I. D. C. G. Silva, “Angiotensin-(1-7) and Human Chorionic Gonadotropin (hCG) Modulate the Nuclear Transcription Factors or Nuclear Receptors Genes in the Tumorigenic Undifferentiated Breast Cancer Cell Line SKBR3,” Journal of Cancer Therapy, Vol. 4, No. 7A, 2013, pp. 70-74. http://dx.doi.org/10.4236/jct.2013.47A011
 S. A. A. Corrêa, S. M. R. Noronha, N. C. Nogueira-deSouza, C. V. V. Carvalho, A. M. M. Costa, J. J. Linhares, M. T. V. Gomes and I. D. G. Silva, “Association between the Angiotensin-Converting Enzyme (Insertion/Deletion) and Angiotensin II Type 1 Receptor (A1166C) Polymorphisms and Breast Cancer among Brazilian Women,” Journal of Renin Angiotensin Aldosterone System, Vol. 10, No. 1, 2009, pp. 51-58. http://dx.doi.org/10.1177/1470320309102317
 S. A. Correa-Noronha, S. A. Ribeiro de Noronha, C. Alecrim, A. D. Mesquita, G. S. Brito, M. G. Junqueira, D. B. Leite, C. V. Carvalho and I. D. Silva, “Association of Angiotensin-Converting Enzyme I Gene I/D Polymorphism with Endometrial but Not with Ovarian Cancer,” Gynecology Endocrinology, Vol. 28, No. 11, 2012, pp. 889-891.